PBH (PBH) SVP Jose Rosado receives 3,426 restricted stock units in grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Prestige Consumer Healthcare senior vice president Jose Luis Rosado reported receiving 3,426 shares of common stock on January 6, 2026, at a price of $0 per share, bringing his direct holdings to 3,436 shares.
The award represents restricted stock units that are scheduled to fully vest on January 6, 2030, indicating a long-term, equity-based component to his compensation aligned with the company’s future performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Rosado Jose Luis
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.01 per share | 3,426 | $0.00 | -- |
Holdings After Transaction:
Common Stock, par value $0.01 per share — 3,436 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did PBH executive Jose Luis Rosado report?
Jose Luis Rosado reported acquiring 3,426 shares of Prestige Consumer Healthcare common stock at $0 per share. This equity award increased his directly held shares to 3,436, reflecting stock-based compensation rather than an open-market purchase.
When did the PBH insider transaction by Jose Luis Rosado occur?
The reported transaction occurred on January 6, 2026. On this date, Jose Luis Rosado received 3,426 shares of Prestige Consumer Healthcare common stock as part of an equity award, with no cash price paid per share in the transaction.
What type of equity award did PBH grant to Jose Luis Rosado?
The filing indicates an award of restricted stock units tied to Prestige Consumer Healthcare common stock. These units convert into shares over time, aligning executive compensation with long-term company performance rather than immediate cash payments.
When do Jose Luis Rosado’s restricted stock units in PBH vest?
The restricted stock units granted to Jose Luis Rosado are scheduled to vest on January 6, 2030. Vesting on this future date means he must remain eligible until then to fully realize the underlying shares.